![Glenn Alfons Friedrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Glenn Alfons Friedrich
Director de Operaciones en Kymab Ltd. .
Cargos activos de Glenn Alfons Friedrich
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Director de Operaciones | - | - |
Wrnch, Inc.
![]() Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - | - |
Historial de carrera de Glenn Alfons Friedrich
Antiguos cargos conocidos de Glenn Alfons Friedrich.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BCM Technologies, Inc.
![]() BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Director de Investigación - Acciones | 01/01/2005 | 01/01/2007 |
Analista de Capital Privado | 01/01/2005 | 01/01/2007 | |
LEXICON PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - | - |
Progression Therapeutics, Inc.
![]() Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Director/Miembro de la Junta | 18/08/2009 | - |
Corporate Officer/Principal | - | 18/08/2009 | |
Ceros Pharmaceuticals, Inc.
![]() Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Fundador | 18/08/2009 | - |
Corporate Officer/Principal | 01/01/2000 | 18/08/2009 |
Formación de Glenn Alfons Friedrich.
University of Alberta | Undergraduate Degree |
Baylor College of Medicine | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Canadá | 3 |
Reino Unido | 2 |
Operativa
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Director of Research - Equity | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
BCM Technologies, Inc.
![]() BCM Technologies, Inc. Investment ManagersFinance BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas. | Finance |
Ceros Pharmaceuticals, Inc.
![]() Ceros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceros Pharmaceuticals, Inc. develops compounds to treat osteoporosis. The company is based in Houston, TX. The company was founded by Glenn Alfons Friedrich. Ceros Pharmaceuticals was acquired by Auxeris Therapeutics, Inc. on January 14, 2004. | Health Technology |
Progression Therapeutics, Inc.
![]() Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX. | Health Technology |
Kymab Ltd.
![]() Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Wrnch, Inc.
![]() Wrnch, Inc. Packaged SoftwareTechnology Services Wrnch, Inc. operates as computer vision Software Company. It is an automated human motion capture system that takes 2D video and outputs 3D skeletonal animation data. The company was founded by Paul Kruszewski and is headquartered in Montreal, Canada. | Technology Services |